Regeneron Pharmaceuticals, Inc. (REGN)
735.20
+0.39
(+0.05%)
USD |
NASDAQ |
Oct 02, 16:00
735.13
-0.07
(-0.01%)
After-Hours: 20:00
Regeneron Pharmaceuticals Price : 735.20 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 740.50 | 742.50 | 729.20 | 735.20 | 613950.0 |
| Oct 01, 2026 | 766.53 | 777.43 | 726.02 | 734.81 | 1.043M |
| Sep 30, 2026 | 749.84 | 763.72 | 742.94 | 758.27 | 872457.0 |
| Sep 29, 2026 | 745.85 | 752.47 | 741.83 | 750.51 | 804336.0 |
| Sep 28, 2026 | 778.09 | 780.94 | 750.00 | 752.25 | 1.150M |
| Sep 25, 2026 | 803.87 | 803.87 | 784.13 | 788.04 | 592146.0 |
| Sep 24, 2026 | 801.59 | 807.20 | 789.39 | 796.02 | 602654.0 |
| Sep 23, 2026 | 805.23 | 813.53 | 790.02 | 801.82 | 721110.0 |
| Sep 22, 2026 | 802.48 | 811.66 | 791.31 | 803.90 | 600266.0 |
| Sep 21, 2026 | 786.03 | 801.44 | 779.96 | 798.17 | 704527.0 |
| Sep 18, 2026 | 787.34 | 794.73 | 779.65 | 784.85 | 2.473M |
| Sep 17, 2026 | 781.18 | 789.99 | 774.78 | 789.45 | 702816.0 |
| Sep 16, 2026 | 775.82 | 779.98 | 771.80 | 774.61 | 382945.0 |
| Sep 15, 2026 | 788.53 | 788.58 | 769.57 | 774.11 | 540837.0 |
| Sep 14, 2026 | 791.98 | 798.84 | 779.45 | 793.74 | 591295.0 |
| Sep 11, 2026 | 800.00 | 800.22 | 780.81 | 781.49 | 443987.0 |
| Sep 10, 2026 | 794.36 | 806.14 | 792.00 | 793.26 | 526911.0 |
| Sep 09, 2026 | 803.83 | 808.63 | 796.72 | 807.65 | 621458.0 |
| Sep 08, 2026 | 814.36 | 821.17 | 799.42 | 810.31 | 556537.0 |
| Sep 04, 2026 | 840.06 | 841.54 | 825.83 | 827.72 | 561170.0 |
| Sep 03, 2026 | 858.18 | 859.34 | 837.63 | 843.47 | 496255.0 |
| Sep 02, 2026 | 826.24 | 854.49 | 825.77 | 852.03 | 749453.0 |
| Sep 01, 2026 | 808.86 | 824.63 | 804.32 | 823.82 | 682806.0 |
| Aug 31, 2026 | 782.44 | 802.78 | 779.08 | 799.08 | 894268.0 |
| Aug 28, 2026 | 809.40 | 809.40 | 789.08 | 794.19 | 488305.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gilead Sciences, Inc. | 144.74 |
| Alnylam Pharmaceuticals, Inc. | 219.72 |
| Amgen, Inc. | 403.04 |
| Incyte Corp. | 115.30 |
| Vertex Pharmaceuticals, Inc. | 504.73 |
Price Related Metrics
| PE Ratio | 18.17 |
| PS Ratio | 5.069 |
| PEG Ratio | 9.300 |
| Price to Book Value | 2.397 |
| Price to Free Cash Flow | 22.02 |
| Earnings Yield | 5.50% |
| Market Cap | 76.02B |
| PEGY Ratio | 7.395 |
| Operating PE Ratio | 18.87 |
| Normalized PE Ratio | 17.14 |